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Objective: Early diagnosis is of proven benefit in Prader-Willi syndrome (PWS). We therefore examined key perinatal features to aid 
early recognition. 
Methods: Data were collected from case records of subjects attending a multi-disciplinary clinic and from a retrospective birth 
questionnaire. 
Results: Ninety patients (54 male-36 female) were seen between 1991-2015, most with paternal deletion (n=56) or maternal isodisomy 
(n=26). Features included cryptorchidism in 94% males, preterm birth (26%), birthweight <2500 g (24%), polyhydramnios (23%), 
breech presentation (23%) and need for nasogastric feeding (83%). Reduced fetal movements (FM) were reported in 82.5% patients 
compared with 4% healthy siblings. Of 35 children born since 1999, 23 were diagnosed clinically within 28 days while diagnosis in 12 
was >28 days: 1-12 months in seven; and 3.75-10.5 years in five. Typical PWS features in these 12 infants included hypotonia (100%), 
feeding difficulties (75%), cryptorchidism (83% males) and reduced FM (66%). Causes other than PWS including neuromuscular disease 
were considered in nine patients. 
Conclusion: Neonatal hypotonia, reduced FM, feeding difficulties and cryptorchidism should immediately suggest PWS, yet late diagnosis 
continues in some cases. Awareness of the typical features of PWS in newborn units is required to allow prompt detection even in the 
presence of confounding factors such as prematurity. 
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ORI GI NAL AR TIC LE
What is already known on this topic?
What this study adds?
Early diagnosis in Prader-Willi syndrome allows appropriate management of feeding difficulties to be implemented and is important for 
counselling as well as minimising parental uncertainty and anxiety. The prevalence of preterm birth and low birthweight is increased in 
Prader-Willi syndrome and is a potential source of diagnostic confusion.
Although the prevalence of preterm birth (26%) and low birthweight (24%) is increased in Prader-Willi syndrome, diagnosis in preterm 
infants is not significantly delayed. However, clinical diagnosis in our cohort was made later than 28 days in 34% of the patients despite 
presence of classic features of hypotonia and cryptorchidism in males and need for nasogastric feeding in over 80%. Comparison with 
non-affected siblings shows that mothers detect reduced fetal movement in 80% of patients with Prader-Willi syndrome, a feature which 
can facilitate early diagnosis. 
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Introduction
Prader-Willi syndrome (PWS) is a neurodevelopmental 
disorder resulting from absence of paternally imprinted 
genes in the 15q11-13 region, caused by deletion in the 
paternal chromosome (del15q) in about 70% of cases or 
disomy of the maternal chromosome [maternal uniparental 
disomy of chromosome 15 (mUPD15)] in about 25% 
(1). The natural history of PWS is complex, with different 
phenotypic features developing at different ages (2,3). 
Before the advent of confirmatory molecular genetic testing, 
diagnosis was made solely according to age-related clinical 
criteria (4). Prompt diagnosis of PWS is not only beneficial 
for educating families about the condition but also for 
facilitating early therapeutic interventions such as speech 
therapy, physiotherapy and dietetics to help with feeding 
difficulties and prevent early onset obesity (5,6,7). Moreover, 
timely diagnosis will enable growth hormone (GH) therapy 
to be implemented early so as to improve linear growth and 
motor development (8). So typical are the features of PWS 
that, especially with publications highlighting the phenotype 
(9,10,11,12,13,14) and widely available molecular genetic 
analysis, it might be expected that diagnosis would be made 
at, or shortly after, birth. 
Hypotonia is a relatively common problem in the newborn 
period, affecting not only otherwise healthy preterm infants 
but also those with sepsis, neurological disease and metabolic 
disorders. The challenge to the clinician, therefore, is to 
identify the minority of infants with PWS from the majority 
of babies in whom hypotonia is a transient feature and from 
those who are suffering from a different condition such as 
spinal muscular atrophy (SMA) (15). Our clinical experience 
indicates that the diagnosis of PWS continues to be made 
beyond the newborn period in some cases. 
An increased incidence of preterm birth and low birth 
weight (LBW) has been reported in PWS, together with 
obstetric symptoms such as reduced fetal movement (FM), 
polyhydramnios and malpresentation (16,17,18). Some 
typical features of PWS infants, such as hypotonia and 
inability to suck necessitating tube feeding, are also common 
in unaffected preterm infants. It might be conjectured, 
therefore, that the diagnosis of PWS is more difficult when 
the infant is preterm. 
A multidisciplinary PWS clinic has been held at our centre 
in the Royal Hospital for Children in Glasgow since 1991, 
providing data on a heterogeneous Scottish cohort. The 
aim of the study was to identify key diagnostic features of 
PWS to facilitate early diagnosis. These include obstetric 
and newborn data, feeding difficulties requiring assisted 
feeding and the prevalence of reduced FMs. In addition, we 
looked for an association between prenatal and perinatal 
characteristics and genotype, to further develop previous 
work (16,17,18).
Methods
All patients with proven PWS attending the multidisciplinary 
clinic in Glasgow, Scotland, since its inception in 1991 until 
December 2015 were included. Data on genotype, BW, 
gestation, delivery method, obstetric symptoms, postnatal 
complications and timing of diagnosis were collected 
and analysed from three sources: a birth questionnaire 
completed by the parent(s); the subject’s case records; and 
maternal obstetric records, when available. It was decided, 
however, that the systematic recording of phenotypic 
features such as hair and eye colour, bifrontal narrowing, 
characteristic eyes, small hands and feet and weak cry 
should not be included within the scope of the study. This 
is because these data were recorded inconsistently, if at all, 
during the newborn period and by multiple observers and 
it was felt appropriate to confine this retrospective study to 
the collection of hard data. 
Endocrine problems were documented by detailing the 
number of patients undergoing GH stimulation testing 
either with insulin or arginine and the outcome, and defining 
GH deficiency as peak values <15 mU/L. The numbers of 
patients treated with GH injections as well as the numbers 
of patients diagnosed with either hypothyroidism or cortisol 
deficiency were also documented. 
The questionnaire invited parents with more than one child 
to submit information on the BW, gestation and delivery 
method of their other children. Mothers were also asked to 
retrospectively estimate the degree of in utero FM in their 
affected and unaffected children using a simple 5 point 
scoring system ranging from 1: much less than expected to 
5: much more than expected. 
BW was assessed according to United Kingdom reference 
standards (Least Mean Square Growth program; http://
www.healthforallchildren.com) and expressed in kilograms 
and standard deviations (SD). The incidences of preterm 
birth (gestation <37 completed weeks), LBW, defined as 
BW <2500 g, small for gestational age (SGA), defined as 
BW <10th percentile and operative delivery were compared 
with healthy siblings and contemporary Scottish population 
data (19). 
Statistical Analysis
All analyses were done using Minitab (version 13.1) at a 
significance level of 5%. Data distribution was assessed 
for normality using Anderson-Darling test. Parametric data 
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are presented as mean (± SD) and non-parametric data 
as median (range) or median (range) (interquartile range) 
Quantitative variables were compared using t-tests and 
analysis of variance or Kruskal-Wallis and Mann-Whitney 
U tests. Qualitative variables were compared using chi-
squared or Fisher’s exact tests. 
Ethical Aspects
Approval was initially granted by the Ethical Committee 
of the Royal Hospital for Sick Children in Glasgow in 2004 
and data collection completed in 2011. Following the tragic 
loss of the lead investigator, Wendy Paterson in 2012, the 
study was relaunched in 2015 to update the data and to 
include more recent patients. This second phase of the 
study was approved by the National Health Service of the 
United Kingdom Research Ethics Authority (reference 15/
NW/0900). In both study periods written informed consent 
was obtained from parents/guardians and subjects aged ≥16 
years while children <16 years were invited to give assent.
Results
Ninety (54 male) subjects with PWS born between 1950 and 
2015 (median 1994) were included in the study (Table 1). 
Excluding eight deaths (male/female=5/3) at the ages of 15, 
18, 23, 25, 27, 27, 29 and 45 years, the median (range) age of 
82 patients on 01/01/2016 was 20.8 (0.9-65.7) years. Twenty-
nine patients had undergone GH stimulation testing of whom 
17 were GH insufficient-median (range) levels 7.2 (<0.1-14.8) 
mU/L; and 12 were GH sufficient-levels 31.6 (17.4-78.1 mU/L). 
A total of 20 patients were treated with GH injections during 
the study period. Hypothyroidism was not documented, and 
no patient was referred with elevation of thyroid stimulating 
hormone on newborn screening programme, which was 
introduced in Scotland in 1979. No patient was diagnosed 
with adrenal insufficiency during the study period, or received 
hydrocortisone therapy. 
Questionnaires were sent to 72 families and returned by 
60 (83%). Reasons for questionnaires not being sent to 18 
families included adoption/fostering and parents no longer 
being contactable. Comparative birth data were collected for 
97 siblings (56 male). 
Genetics
Genetic diagnosis of PWS was confirmed in 89 of the 90 
subjects, as follows: paternal deletion (del15q) in 56 (62%); 
maternal disomy (mUPD15) in 26 (29%); translocation 
(chromosome 15-16) in one (1%); imprinting defect in 
two (2%) and four tested elsewhere (4%). One subject was 
initially reported to have no defect on standard PWS genetic 
screening but later Comparative Genomic Hybridization 
Array analysis revealed a deletion in paternal 15q11.2 
incorporating the NDN (NECDIN) gene (OMIM 602117). NDN 
is important for normal hypothalamic development and it 
has been suggested that loss of NDN contributes to both the 
hypothalamic hypogonadism and neurological features of 
PWS (19). No defect was found in one other, older subject 
who nevertheless satisfied the Holm consensus criteria for 
PWS (4).
Prenatal, Perinatal and Postnatal Data
Data for all PWS subjects and a comparison between term 
and preterm infants are shown in Table 1. Mean (± SD) BW 
was significantly lower in the study group versus healthy 
siblings: 2.68 (0.6) (n=89) vs 3.34 (0.6) kg (n=91); and 
-1.03 (1.03) vs -0.182 (1.02) SD (p<0.001); prevalence of 
SGA significantly higher -32/89 (36%) versus 10/91 (11%). 
Median (range) PWS gestation was lower at 39 (30-43) versus 
40 (33-42) weeks while preterm birth occurred significantly 
more often; in 23 (25.8%) patients compared with three 
(3.2%) siblings (p=0.03). 
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Table 1. Prenatal, perinatal and postnatal characteristics of 90 patients with Prader-Willi syndrome seen in a single 
centre between 1991 and 2015 according to term and preterm status
PWS all  
(n=90)
PWS term  
(n=66)
PWS preterm  
(n=23)
Term vs 
preterm
Gender (M/F) 54/36 40/26 13/10
Median (range) BW (kg) 2.68 (1.18-3.99)  (n=89) 2.97 (1.9-3.99) (n=66) 1.95 (1.18-2.78) (n=23) p<0.001
Median (range) BW SDS (n) -1.10 (-3.27 to 1.92) (89) -1.12 (-3.27 to 1.12) (66) -0.62 (-3.21 to 1.92) (23) p=0.26
%SGA 36 (n=32/89) 36.4 (n=24/66) 34.8 (n=8/23) p=0.9
Median (range) gestation (wks) 39 (30-43) (n=89) 40 (37-43) (n=66) 34 (30-36) (n=23) p<0.001
Median (range) duration of hospital stay 
(days)
27 (0-730) (n=71) 21 (1-730) (n=51) 36.5 (0-134) (n=20) p=0.01
Median (range) duration of NGF (days) 30 (2-480) (n=71) 25 (3-480) (n=50) 42 (2-231) (n=21) p=0.04
Median (range) fetal movement score 1 (1-4) (n=80) 2 (1-4) (n=60) 1 (1-3) (n=20) p=0.05
Time to clinical diagnosis (days) 70 (1-16801) (n=87) 152 (1-16801) (n=65) 24 (2-2995) (n=22) p=0.16
PWS: Prader-Willi syndrome, BW: birthweight, SDS: standard deviation scores, SGA: small for gestational age, wks: weeks, NGF: nasogastric feeding, 
Polyhydramnios was reported in 10/44 (22.7%) mothers. 
Breech presentation was recorded in 15/65 (23.1%) with 
one transverse lie. Mode of delivery was spontaneous vaginal 
in 38/86 subjects (44%), Caesarean section in 38/86 (44%), 
forceps-assisted delivery in six and ventouse extraction in 
three. FMs were reduced with a median score in PWS of 1 in 
the preterm and 2 in the term infants respectively (Table 1). 
Figure 1 shows that whereas sibling gestation was normally 
distributed, the PWS group suggested a bimodal, flattened 
distribution with peaks at both 34 and 40 weeks. This was 
more marked in the del15q than the mUPD15 groups. 
Fetal Movement Scores 
Decreased FM were present in 66/80 (82.5%) with normal 
movement in 14 (17.5%). Figure 2 shows comparison 
between 55 patients (including six with normal movement) 
and their unaffected siblings, with significantly lower 
scores for PWS (p<0.001). Mothers who had had non-
affected babies (n=55) scored their affected babies 
significantly lower (p=0.02) than those who had had only 
one (affected) baby (n=25)-median scores 1 versus 2. 
Thus 8/25 (32%) of the mothers with experience of only 
one pregnancy, carrying a PWS-affected infant, reported 
normal FMs compared with 6/55 (11%) of those with more 
than one child although the FM scores for the former group 
were still significantly lower than for unaffected children 
(p<0.001). 
Feeding Difficulties
Nasogastric feeding (NGF) was given to 75 (86%) infants with 
no assisted feeding in 12 and no data in three. Six of the infants 
who did not receive assisted feeding were diagnosed after four 
months of age. Median (range) duration of NGF in days was 
30 (2-480) (n=71) and was longer in preterm (n=21) at 42 
(2-231) than in term infants (n=49) at 25 (3-480). 
Hypogonadism in Male Prader-Willi Syndrome Infants
Data on testicular position was available in all but five 
of the 54 males. Forty-six (94%) of the 49 boys had 
cryptorchidism, which was bilateral in 40, unilateral in five, 
unspecified in one. Only three (5.5%) male patients had 
normally descended testes. Cryptorchidism was present in 
all but one of the 12 preterm males. 
Hypoplasia of Labia Minora in Female Prader-Willi Syndrome 
Infants
This was documented as present in six girls at birth, not 
present (i.e. normal) in a further six, and not documented 
otherwise. 
Timing of Clinical and Molecular Diagnosis 
Table 1 shows that age at clinical diagnosis was extremely 
variable during the study period and also that preterm 
infants were diagnosed sooner than term infants although 
this difference was not significant. 
Table 2 shows data on the timing of clinical (n=87) and 
genetic diagnosis (n=83) with subjects stratified by 
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Figure 1. Comparison of gestational age between 89 Prader-
Willi syndrome patients and 93 unaffected siblings
Fetal movements were retrospectively scored by the mothers as 1: much less 
than expected, 2: a bit less than expected, 3: about as much as expected, 4: 
a bit more than expected and 5: a lot more than expected
Sibs: siblings, PWS: Prader-Willi syndrome
Figure 2. Comparison of fetal movement in 55 Prader-Willi 
syndrome subjects and 93 unaffected siblings 
Sibs: siblings, PWS: Prader-Willi syndrome
decade of birth. Median (range) age at diagnosis during the 
study period was 2.3 months (1 day-46 years) for clinical 
and 10 months (4 days-46.5 years) for genetic diagnosis. 
Since 1991, time to genetic diagnosis has been 28 days 
(4 days-10.6 years). Age at diagnosis showed an apparent 
improvement during the study period although the number 
of as yet undiagnosed patients, particularly during the 2010-
2015 period, remains uncertain.
Age at Clinical Diagnosis in Patients Born from the Year 2000 
Onwards 
Analysis of patients born since 1 January 2000 showed that 
of 35 patients (16 males) the clinical diagnosis was made 
within the first week of life in 12 infants, between days 8 
and 27 in 11, aged 4 weeks to 12 months in seven, and after 
5 years in five. Among the 12 infants who were diagnosed 
clinically within a week of birth, sepsis was considered in two 
and neuromuscular disease in another. Table 3 gives details 
on the 12 patients diagnosed ≥4 weeks from year 2000 
onwards. Feeding difficulties and hypotonia at birth were 
present in all these patients, with NGFs given to nine. Other 
features included reduced FMs (9), prematurity (4), LBW (4), 
and bilateral cryptorchidism (5/6 males). Hypotonia was 
attributed in three cases to birth asphyxia, birth injury and 
benign congenital hypotonia. Magnetic resonance imaging 
(MRI) was carried out in three. Five children had developed 
hyperphagic obesity by the time that PWS was confirmed. 
Genotype vs Prenatal and Perinatal Features
Table 4 shows that both maternal and paternal age were 
significantly greater in the mUPD15 group compared with 
the del15q group. Also, median year of birth was later 
in the mUPD15 group than in the del15q group-2004 vs 
1994-although this was not significant (p=0.11). The 
prevalence of diminished FMs, birthweight and gestation 
and operative delivery was similar between the two groups. 
Discussion
This study of 90 patients with PWS, drawn from a 
geographically defined area over a 25-year period, 
confirms and extends existing knowledge of the 
prenatal, perinatal and postnatal features of PWS, the 
dominant trait being presence of hypotonia. It should be 
noted that our study is confined to describing only those 
infants whose hypotonia was caused by PWS so that the 
prevalence of neonatal hypotonia in Scotland during the 
study period and hence the proportion of those hypotonic 
infants who actually had PWS is unknown. 
Intrauterine hypotonia causes polyhydramnios, 
malpresentation and reduced FMs leading to an increased 
prevalence of operative delivery. All these features were 
seen in this study, consistent with previous reports 
(9,12,17,18). Of note, breech presentation was found in 
23% of our cohort compared with 0.2% in the Scottish 
population while 44% were delivered by caesarean 
section in contrast to Scottish population data showing a 
rate of 8.6% in 1975-76, rising to 29.9% in 2014-15 (20). 
We found increased incidence of LBW (23.6%) and SGA (36%), 
contrasting with 12.7% for SGA in the Scottish population 
(21) although SGA prevalence in PWS has been reported to 
be higher, ranging from 53-65% (9,22). It has been suggested 
that SGA in PWS may result from a failure to express paternal 
genes which improve placental function (22).
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Table 2. Mean ± standard deviation and median (range) times (days) to clinical (n=87) and molecular (n=83) 
diagnosis by decade of birth
Decade of birth Mean ± SD Median (range) (IQR) p compared to 
prior decade
Comparison between all 
decades p
Clinical diagnosis
<1980 (n=19) 3558±4548 1468 (194-16801) (840-4200) - -
1980-1989 (n=17) 415±681 97 (1-2557) (9-612) p<0.001 -
1990-1999 (n=16) 248±422 74 (1-1534) (3-225) p=0.61 p<0.001
2000-2009 (n=26) 404±887 19 (2-3835) (7-128) p=0.91 -
>=2010 (n=9) 6.1±3.4 5.0 (2-12) (3.5-9) p=0.01 -
Molecular diagnosis
<1980 (n=16) 8797±3458 8401 (4556-16984) (6452-10319) - -
1980-1989 (n=18) 3890±2556 3658 (183-8949) (1544-5470) p<0.001 -
1990-1999 (n=15) 276±494 73 (4-1790) (14-293) p<0.001 p<0.001
2000-2009 (n=25) 476±958 56 (7-3857) (13-228) p=0.82 -
>=2010 (n=9) 11.8±4.52 12.0 (5-19) (7.5-15) p=0.006 -
SD: standard deviation, IQR: interquartile range
The prevalence of preterm birth (25.8%) in our cohort 
markedly exceeds the current Scottish figures of 7.3% 
(19). This increase is similar to Lionti’s study (27.4%) 
(22) and higher than two earlier French studies which 
reported rates of 13/86 (15%) and 2/19 (10.5%) versus 
6% in the general population (12,17). Preterm birth in 
PWS may be partly due to polyhydramnios from reduced 
fetal swallowing causing uterine distension and inducing 
early labour (14,17). The distribution of gestational 
age seen in our cohort appeared to be bimodal. This 
finding has been previously reported by Butler et al 
(16). However these authors report bimodal distribution 
only in mUPD15 whereas we found bimodality only in 
the deletion group. More data on larger populations are 
needed to confirm this possible bimodal pattern. 
In contrast to our expectations that features in common 
with prematurity might cause delay in the diagnosis of 
PWS, we found that affected premature infants tended 
to be diagnosed earlier than their term counterparts. 
This might be attributable to preterm infants receiving 
more clinical attention as well as having a longer stay in 
hospital. 
While most prenatal features of PWS, such as 
polyhydramnios and abnormal presentation are too 
non-specific to be of value, reduced FM is of importance 
in indicating the congenital nature of the hypotonia, 
prompting consideration of disorders such as PWS or 
neurological conditions such as SMA. Careful comparison 
of maternal retrospective evaluation of FMs in affected 
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Table 3. Clinical data on 12 of 35 children with Prader-Willi born from the year 2000 onwards in whom clinical 
diagnosis was made at or after 28 days
Patient 
no
Sex Age at 
clinical 
diagnosis
FM 
score
BW 
(kg)
Gestation 
(weeks)
Floppy at 
birth?
UDT NGF 
(duration)
Comment
 1 M 4 w 1 1.96 36 y b y (4 w) Had MRI of brain for possible neurological 
diagnosis
 2 M 4 w 2 3.38 39 y b y (12 m) Diagnosed at end of newborn period
 3 M 4 w 3 2.5 42 y b n Poor suck and floppy with dislocated hips
 4 F 6 w 1 1.94 34 y y (17 w) Mother noticed very reduced FM compared 
with co-twin
 5 F 7 w 2 2.29 35 y y (2 d) Admitted day 5 with hypothermia, tube fed 
for 2 days, discharged day 10. Diagnosis 
made because of persistent hypotonia
 6 M 3 m 4 2.61 38 y b y (10 m) MRI and EEG carried out in view of 
neonatal hypotonia and poor feeding
 7 F 7 m 1 2.68 38 y y (2 w) Hypotonia attributed to birth asphyxia 
(Apgar 4 at 5 minutes). Persistent 
hypotonia led to diagnosis
 8 F 10.5 y 1 2.76 39 y y (7 d) Very floppy and difficult to feed at birth, 
hyperphagic from 3 years
 9 M 3.9 y 1 2.7 37 b y (4 w) Bruised at birth. MRI scan performed at 3 
w in view of hypotonia and poor feeding. 
Developmental delay and weight gain led 
to diagnosis
 10 F 4.6 y 3 3.24 40 y n “Like a rag doll” with no cry and poor 
feeding. Diagnosed as benign congenital 
hypotonia. Weight gain from 3 years and 
mother suspected PWS from internet
 11 F 3.7 y 3 3.1 41 y y (3 d) Difficult to feed and tube fed briefly. 
Developmental delay followed by increase 
in weight at 3 years prompted diagnosis
 12 M 4.2 y 2 1.8 36 y No n Reduced fetal movement compared to 
siblings reported. Went home day 3. 
Increase in weight noted at 1 year. Initial 
genetic screening reported normal but 
deletion in PWS region detected by CGH 
Array
d: days, m: months, y: years, b: bilateral, F: female, M: male, FM: fetal movement, BW: birthweight, UDT: undescended testis, NGF: nasogastric feeding, MRI: 
magnetic resonance imaging, EEG: electroencephalogram, PWS: Prader-Willi syndrome, CGH: comparative genomic hybridization
and unaffected infants shows a striking difference, with 
82.5% reporting reduced movements in PWS infants. This 
is consistent with the figures of 85% and 88% reported 
in the studies of Miller et al (23) and Gross et al (9), both 
of which assessed FMs using antenatal ultrasound. 
In our study mothers who had only experienced one 
pregnancy with a PWS infant were less likely to score 
FM as low. However, scores given by uniparous mothers 
were still significantly lower than those for the unaffected 
babies of other mothers. Furthermore, preterm infants 
had a lower median score for FMs than term babies, but 
despite this term babies’ scores were still significantly 
lower compared with unaffected babies. Table 3 shows 
that eight of twelve patients diagnosed ≥4 weeks of age 
had reduced FMs, awareness of which could have secured 
earlier diagnosis. Subjective maternal reporting, even 
for uniparous women, appears reliable and increased 
awareness of this among obstetricians and neonatologists 
is important (18). 
The most constant feature of PWS at birth is hypotonia, 
Dudley and Muscatelli citing a 97% incidence (17). 
Gunay-Aygun et al (24) cite “hypotonia with poor suck” 
as the sole factor from birth to two years, sufficient to 
prompt genetic testing for PWS. Feeding difficulty is also 
common in PWS, NGF being instituted in 86% of our 
cohort. Late-diagnosed infants had shorter durations of 
NGF reflecting failure to recognise the condition and its 
severity. In the few cases where NGF was not commenced, 
some mothers described enormous difficulties in feeding 
their infants. The value of prompt diagnosis in reducing 
the period of hospitalisation and duration of NGF has 
been shown by Bacheré et al (25). The very high rate 
of male hypogonadism in PWS is confirmed by this 
study with a prevalence of 90% amongst preterm boys 
compared with 30% prevalence reported in unaffected 
preterm boys (26). 
During the study period the median age at diagnosis of 
PWS appeared to improve with a fall from 9 to 5 days 
between 2000-2009 and 2010-2015. However it is 
important to note that the number of as yet undiagnosed 
children with PWS is currently unknown, and that the 
true median age at diagnosis may prove to be higher. 
Consistent with previous studies we have shown an 
increase in parental age with mUPD15 compared with 
del15q (16). We also showed that the ratio of mUPD15 
to del15q rose during the study, consistent with the rise 
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Table 4. Parental, fetal and perinatal characteristics of 90 patients with Prader-Willi syndrome seen in a single centre 
1991-2015 according to molecular genetic defect
mUPD15 del15q p value
Mean (SD) maternal age (yrs) 
[n]
34.6 (6.2)
[23]
26.4 (6.1)
[51]
<0.001
Mean (SD) paternal age (yrs)
[n]
34.6 (7.2)
[23]
29.6 (6.4)
[49]
0.004
% decreased fetal movement scores
[n]
79.2
[19]
81.6
[40]
0.91
% Caesarean section 
[n]
40
[10]
49.1
[27]
0.54
% Vaginal delivery
[n]
56
[14]a
50
[28]b
0.54
Median (range) gestation (weeks)
[n]
38 (32-42)
[25]
39 (30-43)
[56]
0.52
Preterm <37 weeks 
(%)
6/25
(24)
16/56
(28.6)
0.66
Mean (SD) birth weight
[n]
2.73 (0.57)
[25]
2.60 (0.57)
[56]
0.36
Mean (SD) birth weight SDS 
[n]
-0.82 (0.83)
[n=25]
-1.18 (1.01)
[56]
0.13
Number (%) SGA 
[n]
5 (20)
[25]
25 (44.6)
[56]
0.02
mUPD15: maternal uniparental disomy of chromosome 15, del15q: deletion in 15q 11-13 region of paternal chromosome, a: includes two forceps and one 
ventouse deliveries; b: includes three forceps and two ventouse deliveries, SGA: small for gestational age, SD: standard deviation
in parental ages in Scotland between 1977 and 2015-
from 26.1 to 29.4 and 28.6 to 32.3 years for mothers 
and fathers respectively (20). The relationship between 
maternal age and disomy has been hypothesized to result 
from a phenomenon known as trisomy rescue (16,27). 
No other significant difference was found between the 
two genotypes. 
Early diagnosis in PWS is highly desirable. Therapies 
to counter muscular hypotonia, including GH therapy 
and physiotherapy training programmes, may be 
especially useful in the early years. During this period 
PWS infants and young children may have impaired 
motor development and skill acquisition which has been 
reported to affect further development of social abilities 
and cognitive function (5). GH production is reduced 
at all ages in PWS but is more marked at younger ages 
and reduced muscle mass is present from infancy so 
that early GH therapy may alleviate deficits associated 
with PWS hypotonia, including improved cognitive 
development (7,8). Moreover, feeding difficulties are 
a major problem during infancy and early detection of 
PWS enables speech and language therapy help with 
this problem as well as with language acquisition and 
cognitive development. Indeed, so prevalent are feeding 
difficulties and the need for NGFs in PWS that this 
diagnosis can be virtually excluded in older patients with 
obesity and developmental delay if there is no history of 
neonatal feeding problems. Beyond infancy parents and 
carers need to restrict calorie intake in order to prevent 
the onset of obesity (5,6). Thus an additional benefit of 
early diagnosis is the opportunity to educate parents and 
others involved in the welfare of the patient as to the 
natural history of this complex condition and to not only 
care for the child, but also to seek help themselves, when 
necessary (5,7,8). 
Given the typical features of PWS, particularly the 
findings of hypotonia and feeding difficulty at birth, it 
might be expected that diagnosis would be consistently 
early. The additional feature of cryptorchidism in almost 
all males is most helpful, especially when combined with 
hypotonia. By contrast, hypoplasia of the labia minora 
was documented in only a minority of female patients. 
This partly reflects the lack of systematic documentation 
during the study period, but also the limited diagnostic 
value of such a subjective feature. The finding of 
unexplained hypotonia at birth, especially if accompanied 
by undescended testes in boys, should immediately 
prompt a search for the phenotypic features of PWS. 
These include characteristic up-slanting eyes with narrow 
palpebral fissures (so-called “almond eyes”), narrow 
nose, bi-frontal narrowing and sticky saliva resulting in 
the “string sign” (28), small hands and feet, and weak 
cry. Whilst we decided that it was not possible in this 
retrospective study to accurately quantify and evaluate 
these traits individually, a constellation of these features 
in a hypotonic infant is an important adjunct to diagnosis. 
However, we would argue that it is actually making 
the essential connection between neonatal hypotonia 
and the possibility of PWS in the first place-which only 
then prompts a search for phenotypic features-which is 
essential and yet not being made consistently in clinical 
practice in our experience. Thus our study shows that in 
Scotland diagnosis of PWS was first suspected well after 
the first week of life in 34% of patients during the past 
15 years. This is despite the presence of hypotonia in all 
12 of the late-diagnosed cases with recourse to NGF in 
nine, reduced FMs in eight, and cryptorchidism in 5/6 
boys. 
Also, the distress caused to parents when diagnosis 
is delayed, even for a matter of days, should not be 
underestimated, especially when investigations for 
neurological disease, such as MRI and muscle biopsy 
are contemplated. The mother of patient 7 in Table 3, 
eventually diagnosed at 9 months, wrote “As the hospital 
didn’t know what was wrong we were not allowed to go 
home until our daughter could take the bottle. We secretly 
cup fed her so as to be able to get home as they wouldn’t 
let us tube feed. On finding out about her condition we 
realised that she ticked all the boxes and we feel that the 
hospital should have recognised the condition. Instead 
we were told she had cerebral palsy.” 
Study Limitations
The main limitation of our study was its retrospective 
nature. However, in including all genetically proven PWS 
patients who have attended our clinic up to 2015, our 
cohort size was maximised. In addition, a temporal 
analysis of the speed of clinical and molecular diagnosis 
at a dedicated, specialised PWS clinic was made possible. 
A further limitation of our study was the subjective 
nature of data obtained from the mothers, especially 
concerning the degree of FM in affected and unaffected 
children. It is reassuring to compare the subjective recall 
of our mothers which proved to be consistent with the 
radiologically measured degree of FM reported by Miller 
et al (23) and Gross et al (9). 
In our opinion the diagnosis of PWS can and should be 
made within days of birth provided that the hypotonia and 
the feeding difficulties, which will invariably be evident 
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to the mother and midwife, are appreciated. Subsequent 
rapid genetic confirmation of PWS is essential since 
previous work in our centre showed clinical misdiagnosis 
in 11/31 patients at the time our multi-disciplinary clinic 
was established (29). In the present study only one 
patient did not show molecular genetic evidence of PWS 
despite fulfilling the Holm criteria. 
Conclusion
We believe that, although features such as preterm birth, LBW, 
SGA, operative delivery and malpresentation are not specific 
to PWS, their combined presence in the context of hypotonia 
and feeding difficulties should evoke PWS. Indeed it has been 
suggested that when a combination of polyhydramnios, SGA 
and asymmetric intrauterine growth co-exist in the absence 
of morphological abnormalities, prenatal methylation studies 
for PWS should be performed (9). 
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